SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex -- Ignore unavailable to you. Want to Upgrade?


To: santhosh mohan who wrote (162)11/28/1997 11:44:00 AM
From: Bob Swift  Respond to of 656
 
I think they did come out the next day saying they have cofidence in their drug. I saw the news headline on my quotrek but could not find the details on Yahoo or anywhere else.



To: santhosh mohan who wrote (162)11/28/1997 11:49:00 AM
From: Bob Swift  Read Replies (1) | Respond to of 656
 
>>Wonder if Bristol-Myers-Squibb is going to fight the application.<<
What do you think ? Bristol-Myers-Squibb is going to fight it big time.I won't buy IMNX because of this application filing although I am still very tempted by the RA drug to get back in towards the end of the year.



To: santhosh mohan who wrote (162)11/29/1997 12:32:00 AM
From: Charles Hill  Respond to of 656
 
Santhosh --- If my information is correct, and I think it is, the company was advised to take the high road regarding the Montgomery downgrade and let Enbrel's results speak for themselves.